Management of acute and chronic kidney disease, thrombotic disorders, glomerulonephritis, epidemiology.
Education and Experience
BS Cum Laude: Duke University, 1997; MD: Medical College of Georgia, 2002; Resident: University of North Carolina, 2002-2005; Clinical Assistant Professor of Medicine: University of North Carolina 2005-2006; Nephrology Fellow: University of North Carolina, 2006-2009; MPH: University of North Carolina, 2010; Research Fellow: University of North Carolina, 2009-2010; Assistant Professor of Medicine: University of North Carolina, 2010-2019; Medical Director: Carolina Dialysis – Siler City, 2013-2016; Medical Director: Carolina Dialysis – Carrboro Home Therapies, 2016-2020; Associate Professor of Medicine: University of North Carolina, 2019-present.
Research and Clinical Interests
Dr. Derebail’s research interests include glomerular disease and vasculitis, understanding the association and pathophysiology of thrombotic disorders in glomerular disease and chronic kidney disease, kidney disease in sickle cell disease, and sickle cell trait as a risk factor for kidney disease. He is involved as an investigator in multiple observational studies and clinical interventional trials. Dr. Derebail’s clinical practice includes seeing patients with glomerular disease and vasculitis including in our Multidisciplinary Vasculitis Clinic and seeing patients in a multidisciplinary Sickle Cell Disease clinic. He is also involved in the management of end-stage kidney disease patients at Carolina Dialysis in Carrboro, NC.
Reynolds ML, Poulton CJ, Blazek LN, Hogan SL, Falk RJ, Derebail VK. Subfertility and early menopause in women with glomerular disease. Nephrol Dial Transplant. 2021 Jan 28.
Reynolds ML, Poulton CJ, Blazek LN, Hogan SL, Falk RJ, Derebail VK. Contraceptive Use and Elective Terminations in Women Enrolled in the Glomerular Disease Collaborative Network. Kidney Int Rep. 2020 Jul 17;5(10):1780-1783.
Derebail VK, Falk RJ. ANCA-Associated Vasculitis – Refining Therapy with Plasma Exchange and Glucocorticoids. N Engl J Med. 2020 Feb 13;382(7):671-673.
Derebail VK, Rheault MN, Kerlin BA. Role of direct oral anticoagulants in patients with kidney disease. Kidney Int. 2020 Apr;97(4):664-675.
Derebail VK, Ciccone EJ, Zhou Q, Kilgore RR, Cai J, Ataga KI. Progressive Decline in Estimated GFR in Patients With Sickle Cell Disease: An Observational Cohort Study. Am J Kidney Dis. 2019 Jul;74(1):47-55.
Mulder N, Nembaware V, Adekile A, Anie KA, Inusa B, Brown B, Campbell A, Chinenere F, Chunda-Liyoka C, Derebail VK, et al. Proceedings of a Sickle Cell Disease Ontology workshop – Towards the first comprehensive ontology for Sickle Cell Disease. Appl Transl Genom. 2016 Mar 15;9:23-9.
Lee T, Derebail VK, Kshirsagar AV, Chung Y, Fine JP, et al. Patients with primary membranous nephropathy are at high risk of cardiovascular events. Kidney Int. 2016 May;89(5):1111-1118.
Naik RP, Derebail VK, Grams ME, Franceschini N, Auer PL, et al. Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans. JAMA. 2014 Nov 26;312(20):2115-25.
Lee T, Gasim A, Derebail VK, Chung Y, McGregor JG, et al. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol. 2014 May;9(5):905-13.
Derebail VK, Lacson EK Jr, Kshirsagar AV, Key NS, Hogan SL, et al. Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose. J Am Soc Nephrol. 2014 Apr;25(4):819-26.
Lee T, Biddle AK, Lionaki S, Derebail VK, Barbour SJ, et al. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney Int. 2014 Jun;85(6):1412-20.
Laurin LP, Nachman PH, Desai PC, Ataga KI, Derebail VK. Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease. Nephrol Dial Transplant. 2014 Jun;29(6):1211-8.
Lionaki S, Derebail VK, Hogan SL, Barbour S, Lee T, et al. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012 Jan;7(1):43-51.
Derebail VK, Nachman PH, Key NS, Ansede H, Falk RJ, Kshirsagar AV. High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol. 2010 Mar;21(3):413-7.